SCHEMBL1463650

SCHEMBL1463650

COC1CCN(CCCCN2C(=O)c3ccccc3C2=O)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.62
MAOB P27338 3/20 0.59
HTR1A P08908 4/20 0.59
HTR7 P34969 2/20 0.59
HRH1 P35367 1/20 0.59
DRD3 P35462 1/20 0.59
HTR2B P41595 1/20 0.59
ALDH1A1 P00352 2/20 0.58
ADRA1D P25100 2/20 0.58
ADRA1A P35348 2/20 0.58
ADRA1B P35368 2/20 0.58
MEN1 O00255 1/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2D6 P10635 1/20 0.58
ALOX12 P18054 1/20 0.58
KMT2A Q03164 1/20 0.58
HIF1A Q16665 1/20 0.58
HSD17B10 Q99714 1/20 0.58
KDM4E B2RXH2 1/20 0.57
GLA P06280 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2250329 0.97 MAOB (0.59) DRD2MAOBHTR1AHTR7HRH1
SCHEMBL2245540 0.83 ALDH1A1 (0.55) DRD2MAOBHTR1AHTR7HRH1
SCHEMBL6620588 0.82 BCHE (0.59) DRD2MAOBHTR1ADRD3
SCHEMBL14028451 0.82 HTR1A (0.79) DRD2MAOBHTR1ADRD3
SCHEMBL5730330 0.81 HTR1A (0.63) DRD2MAOBHTR1AHTR7HRH1
SCHEMBL6619060 0.80 MAOB (0.53) DRD2MAOBHTR1AHTR7HRH1
SCHEMBL5730545 0.80 DRD2 (0.55) DRD2MAOBHTR1AHTR7HRH1
SCHEMBL29459507 0.80 HTR1A (0.62) DRD2MAOBHTR1AHTR7HRH1
SCHEMBL26992312 0.80 HTR1A (0.62) DRD2MAOBHTR1AHTR7HRH1
SCHEMBL3440240 0.79 MAOB (0.73) DRD2MAOBHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110071147-A1 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID AMIDES LUK KIN-CHUN 2011-03-24 US disclosed
US-20050256154-A1 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid amides LUK KIN-CHUN 2005-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256154-A1 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid amides FGFR3, FGFR4, FGFR1 DRD2 3641/4885MAOB 2809/4885HTR1A 2177/4885
US-20110071147-A1 4-AMINO-THIENO[3,2-C]PYRIDINE-7-CARBOXYLIC ACID AMIDES FGFR3, FGFR4, FGFR1 DRD2 3641/4885MAOB 2809/4885HTR1A 2177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.